Analysis of a plerixafor sparing mobilization regimen for autologous hematopoietic cell transplant in multiple myeloma-Reference-Cited by-同舟云学术

Analysis of a plerixafor sparing mobilization regimen for autologous hematopoietic cell transplant in multiple myeloma

Published:2024-08-13 Issue: Volume: Page:
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Cancilla Daniel,Nurse Daniel Paul,Wei Wei,Cenin Danielle,Ferraro Christina,D’Andrea Christopher,Matia Brian,Coffman Julie,Hamilton Betty K.,Srivastava Swati,Sauter Craig,Williams Louis,Khouri Jack

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00277-024-05935-1.pdf

Reference11 articles.

1. Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K, Brown J, Drayson MT, Selby PJ, Medical Research Council Adult Leukaemia Working Party (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 348(19):1875–1883. https://doi.org/10.1056/NEJMoa022340

2. Chang HH, Liou YS, Sun DS (2021) Hematopoietic stem cell mobilization. Tzu Chi Med J 34(3):270–275. https://doi.org/10.4103/tcmj.tcmj_98_21

3. Furundarena JR, Uranga A, Alkorta A, González C, Ferreiro J, Rey J, Aragón M, Urreta L, Emparanza I, Redín JI, Garrido H, A., Araiz M (2020) Evaluation of the predictive value of the hematopoietic progenitor cell count using an automated hematology analyzer for CD34 + stem cell mobilization and apheresis product yield. Int J Lab Hematol 42(2):170–179. https://doi.org/10.1111/ijlh.13142

4. DiPersio JF, Stadtmauer EA, Nademanee A, Micallef IN, Stiff PJ, Kaufman JL, Maziarz RT, Hosing C, Früehauf S, Horwitz M, Cooper D, Bridger G, Calandra G (3102) & Investigators (2009). Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma. Blood, 113(23), 5720–5726. https://doi.org/10.1182/blood-2008-08-174946

5. Greil C, Kiote-Schmidt C, Fink G, Ihorst G, Hildenbeutel S, Bosse R, Duyster J, Engelhardt M, Wäsch R (2017) Successful peripheral blood stem cell mobilization with a cost-efficient single fixed-dose plerixafor schedule in poor mobilizers. Leuk Lymphoma 58(8):1849–1858. https://doi.org/10.1080/10428194.2016.1271946